These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6467029)

  • 1. Loss of intrinsic striatal neurons after methylazoxymethanol acetate treatment in pregnant rats.
    Balduini W; Abbracchio MP; Lombardelli G; Cattabeni F
    Brain Res; 1984 Jul; 317(1):133-6. PubMed ID: 6467029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prenatal methylazoxymethanol treatment on the development of central monoamine neurons.
    Jonsson G; Hallman H
    Brain Res; 1981 Nov; 254(4):513-30. PubMed ID: 6118203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fetal methylazoxymethanol acetate lesion on the synaptic neurochemistry of the adult rat striatum.
    Beaulieu M; Coyle JT
    J Neurochem; 1981 Oct; 37(4):878-87. PubMed ID: 6119358
    [No Abstract]   [Full Text] [Related]  

  • 4. Prenatal exposure to methylazoxymethanol (MAM) acetate: effects on ultrasonic vocalization and locomotor activity in rat offspring.
    Cagiano R; De Salvia M; Renna G; Racagni G; Cuomo V
    Arch Toxicol Suppl; 1987; 11():148-51. PubMed ID: 3477156
    [No Abstract]   [Full Text] [Related]  

  • 5. The sleep-wakefulness cycle and spindle bursts during paradoxical sleep in microencephalic rats induced by prenatal administration of methylazoxymethanol (MAM) acetate.
    Sano K; Matsumoto J
    Tokushima J Exp Med; 1982 Jun; 29(1-2):1-9. PubMed ID: 7147236
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of methylazoxymethanol acetate on adenylate cyclase and 5'-nucleotidase in rat liver plasma membranes.
    Zedeck MS; Swislocki NI
    Cancer Lett; 1975 Nov; 1(2):109-12. PubMed ID: 189900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal methylazoxymethanol acetate-induced lesions cause reductions in dopamine receptor-mediated catalepsy and stereotypy.
    Sanberg PR; Pevsner J; Autuono PG; Coyle JT
    Neuropharmacology; 1985 Nov; 24(11):1057-62. PubMed ID: 4080104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylazoxymethanol-induced microencephaly: persistent increase of cortical somatostatin-like immunoreactivity.
    Cattabeni F; Abbracchio MP; Cimino M; Cocchi D; Di Luca M; Mennuni L; Rosi F; Zaratin P
    Brain Res Dev Brain Res; 1989 May; 47(1):156-9. PubMed ID: 2736763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitatory amino acid receptors in brains of rats with methylazoxymethanol-induced microencephaly.
    Tamaru M; Yoneda Y; Ogita K; Shimizu J; Matsutani T; Nagata Y
    Neurosci Res; 1992 Jun; 14(1):13-25. PubMed ID: 1324453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired selective attention in methylazoxymethanol-induced microencephalic rats.
    Mohammed AK; Jonsson G; Söderberg U; Archer T
    Pharmacol Biochem Behav; 1986 Apr; 24(4):975-81. PubMed ID: 3714788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetally-induced noradrenergic hyperinnervation of cerebral cortex results in persistent down-regulation of beta-receptors.
    Beaulieu M; Coyle JT
    Brain Res; 1982 Aug; 256(4):491-4. PubMed ID: 6290000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizure susceptibility in immature rats with micrencephaly induced by prenatal exposure to methylazoxymethanol acetate.
    de Feo MR; Mecarelli O; Ricci GF
    Pharmacol Res; 1995 Feb; 31(2):109-14. PubMed ID: 7596953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological assessment of functional alterations in the brain of rats exposed prenatally to methylazoxymethanol].
    Yasuda K
    Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):203-11. PubMed ID: 3609968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular expression of somatostatin in MAM-induced microencephaly in the rat.
    Naus CC; Cimino M; Wood GR; Di Luca M; Cattabeni F
    Brain Res Dev Brain Res; 1992 Nov; 70(1):39-46. PubMed ID: 1361885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
    Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
    Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of striatal somatostatin neurons following prenatal methylazoxymethanol.
    Vincent SR; Semba K; Radke JM; Jakubovic A; Fibiger HC
    Exp Neurol; 1990 Nov; 110(2):194-200. PubMed ID: 1977608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal lesions with kainic acid: neurochemical characteristics.
    Schwarcz R; Coyle JT
    Brain Res; 1977 May; 127(2):235-49. PubMed ID: 16686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional sensitization of striatal dopamine D1 receptors in the 6-hydroxydopamine-lesioned rat.
    Pifl C; Reither H; Hornykiewicz O
    Brain Res; 1992 Feb; 572(1-2):87-93. PubMed ID: 1535275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of daytime rearing behavior in methylazoxymethanol-treated rats: methodological considerations.
    Sanberg PR; Henault MA; Moran TH; Antuono PG; Coyle JT
    Behav Brain Res; 1987 Aug; 25(2):97-100. PubMed ID: 3675829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated monoamine levels in the cerebral hemispheres of microencephalic rats treated prenatally with methylazoxymethanol or cytosine arabinoside.
    Matsutani T; Nagayoshi M; Tamaru M; Tsukada Y
    J Neurochem; 1980 Apr; 34(4):950-6. PubMed ID: 7359141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.